Slowing the progression of chronic renal insufficiency

CMAJ. Canadian Medical Association Journal

Volumn 166, Issue 7, 2002, Pages 906-907

  Tonelli, Marcello ^a   Gill, John ^a   Pandeya, Sanjaya ^a   Bohm, Clara ^a   Levin, Adeera ^a   Kiberd, Bryce A ^a  

^a Dickson Building   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE REGULATION; CANADA; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE COURSE; DRUG SAFETY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; NOTE; PROTEINURIA; QUESTIONNAIRE; RISK FACTOR; SODIUM RESTRICTION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036208484     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (13)

1. End-stage renal disease in Canada: Prevalence projections to 2005
2. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data
3. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
4. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease
5. 1999 Canadian recommendations for the management of hypertension
6. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
7. Audit of antihypertensive treatment in patients with renal failure
8. Factors affecting rate of progressive renal decline: Observations in a non-clinical trial setting
9. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
10. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension
11. Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the Systolic Hypertension in the Elderly Program
12. Low-dose diuretic and/or dietary sodium restriction when blood pressure is resistant to ACE inhibitor
13. Clinical practice guidelines for initiation of dialysis